CDC - Meeting of the Advisory Committee on Immunization Practices today: Update risk/benefit of Janssen COVID-19 vaccine - December 16, 2021

[sharon sanders]

https://www.cdc.gov/vaccines/acip/index.html

[sharon sanders]

HEALTH AND SCIENCE
CDC panel recommends Pfizer, Moderna vaccines over J&J shots for adults due to rare blood clot cases


PUBLISHED THU, DEC 16 2021

3:41 PM EST

UPDATED MOMENTS AGO

KEY POINTS

• The Advisory Committee on Immunization Practices voted unanimously to recommend Pfizer and Moderna over the Johnson & Johnson vaccine.
• The CDC has confirmed 54 cases of people developing blood clots and showing low blood platelet levels following J&J vaccination.
• All of the patients were hospitalized, nine people died and 36 were treated in intensive care.

A healthcare worker holds a dose of the Johnson & Johnson vaccine.
Phill Magakoe | AFP | Getty Images

An advisory panel for the Centers for Disease Control and Prevention on Thursday recommended Pfizer and Moderna’s vaccines over Johnson & Johnson’s shot for adults 18 and over, after finding dozens of people developed a rare blood clot condition following J&J vaccination, all of whom were hospitalized and nine of whom died.

The Advisory Committee on Immunization Practices voted unanimously to recommend Pfizer and Moderna over the Johnson & Johnson vaccine. CDC Director Rochelle Walensky still has to accept the recommendation.

The CDC has confirmed 54 cases of people developing blood clots and showing low blood platelet levels, a new condition called thrombosis with thrombocytopenia syndrome that mostly affects younger women. All of the patients were hospitalized, nine people died and 36 were treated in intensive care.

more...

https://www.cnbc.com/2021/12/16/cdc-panel-prefers-pfizer-moderna-vaccines-over-jj-due-to-rare-blood-clot-cases.html

[sharon sanders]

bump this

[Pathfinder]

CDC Endorses ACIP’s Updated COVID-19 Vaccine Recommendations

Media Statement
For Immediate Release: Thursday, December 16, 2021
Contact: Media Relations
(404) 639-3286

Today, CDC is endorsing updated recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the prevention of COVID-19, expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine over Johnson & Johnson’s COVID-19 vaccine. ACIP’s unanimous recommendation followed a robust discussion of the latest evidence on vaccine effectiveness, vaccine safety and rare adverse events, and consideration of the U.S. vaccine supply. The U.S. supply of mRNA vaccines is abundant – with nearly 100 million doses in the field for immediate use. This updated CDC recommendation follows similar recommendations from other countries, including Canada and the United Kingdom. Given the current state of the pandemic both here and around the world, the ACIP reaffirmed that receiving any vaccine is better than being unvaccinated. Individuals who are unable or unwilling to receive an mRNA vaccine will continue to have access to Johnson & Johnson’s COVID-19 vaccine.

The following is attributable to CDC Director, Dr. Rochelle Walensky

“We have made important strides in the year since the COVID-19 vaccination program started. More than 200 million Americans have completed their primary vaccine series, providing protection against COVID-19, preventing millions of cases and hospitalizations, and saving over a million lives. Today’s updated recommendation emphasizes CDC’s commitment to provide real-time scientific information to the American public. I continue to encourage all Americans to get vaccinated and boosted.”

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICESexternal icon

CDC works 24/7 protecting America’s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.

Page last reviewed: December 16, 2021
Content source: Centers for Disease Control and Prevention

https://www.cdc.gov/media/releases/2021/s1216-covid-19-vaccines.html

[sharon sanders]

bump this